Z16.34 - Resistance to antimycobacterial drug(s)
- Applicable to Resistance to antimycobacterial drug(s)
- The 2025 edition of ICD10-CM Z16.34 became effective on October 1, 2024.
- This is the American ICD10-CM version of Z16.34 - other international versions of ICD10 Z16.34 may differ.
- Z16.34 is a Non-Billable / Non-Specific ICD10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- Z16.34 Code should not be used for billing or reimbursement purposes as there are multiple ICD-10 CM codes below it that contain a greater level of detail.
- Z16.34 - Resistance to antimycobacterial drug(s)
- Z16.34 - Resistance to antimycobacterial drug(s)
- Z16.341 - Resistance to single antimycobacterial drug
- Z16.342 - Resistance to multiple antimycobacterial drugs
Inclusion terms help to clarify and specify the conditions or diseases covered by a particular ICD-10-CM code.
Inclusion Term:
- Resistance to tuberculostatics
Non-Billable/Non-Specific Code
The following codes above Z16.34 contain annotation back-references that may be applicable to Z16.34:
- Chapter: Z00-Z99 - Factors influencing health status and contact with health services
- Section: Z16 - Resistance to antimicrobial drugs
- Category: Z16 - Resistance to antimicrobial drugs
Browse other similar CM codes:
Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.
Please, give attribution to our website icd10all.com